| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.274.27.18872 |
| P698 | PubMed publication ID | 10383383 |
| P2093 | author name string | M Edgerton | |
| S E Koshlukova | |||
| M W Araujo | |||
| T L Lloyd | |||
| P433 | issue | 27 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell death | Q2383867 |
| Candida albicans | Q310443 | ||
| P304 | page(s) | 18872-18879 | |
| P577 | publication date | 1999-07-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Salivary histatin 5 induces non-lytic release of ATP from Candida albicans leading to cell death | |
| P478 | volume | 274 |
| Q33427799 | A novel immune evasion strategy of candida albicans: proteolytic cleavage of a salivary antimicrobial peptide |
| Q39253672 | A transmembrane domain and GxxxG motifs within L2 are essential for papillomavirus infection |
| Q36335705 | Anti-candidal activity of a novel peptide derived from human chromogranin A and its mechanism of action against Candida krusei |
| Q42111100 | Antibacterial mechanism and activities of black pepper chloroform extract |
| Q39477082 | Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5. |
| Q91650098 | Antifungal Peptides as Therapeutic Agents |
| Q44387146 | Binding, internalisation and degradation of histatin 3 in histatin-resistant derivatives of Candida albicans |
| Q28205819 | Candida albicans Ssa1/2p is the cell envelope binding protein for human salivary histatin 5 |
| Q39472812 | Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5. |
| Q24290527 | Candidacidal activities of human lactoferrin peptides derived from the N terminus |
| Q42836863 | Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane |
| Q90363547 | Candidalysin Is a Potent Trigger of Alarmin and Antimicrobial Peptide Release in Epithelial Cells |
| Q86791924 | Characterization of colloidal phosphorus species in drainage waters from a clay soil using asymmetric flow field-flow fractionation |
| Q36558457 | Chemical genomic screening of a Saccharomyces cerevisiae genomewide mutant collection reveals genes required for defense against four antimicrobial peptides derived from proteins found in human saliva |
| Q42589056 | Different anti-Candida activities of two human lactoferrin-derived peptides, Lfpep and kaliocin-1. |
| Q35912775 | Differentially expressed proteins in derivatives of Candida albicans displaying a stable histatin 3-resistant phenotype |
| Q34301662 | Distinct antifungal mechanisms: beta-defensins require Candida albicans Ssa1 protein, while Trk1p mediates activity of cysteine-free cationic peptides |
| Q33951838 | Dr. Jekyll/Mr. Hyde: the dual role of extracellular ATP. |
| Q35270572 | Easy strategy to increase salt resistance of antimicrobial peptides |
| Q28365530 | Effects of histatin 5 and derived peptides on Candida albicans |
| Q44682727 | Efficacy of human salivary mucin MUC7-derived peptide and histatin 5 in a murine model of candidiasis |
| Q38626954 | Endocytosis-mediated vacuolar accumulation of the human ApoE apolipoprotein-derived ApoEdpL-W antimicrobial peptide contributes to its antifungal activity in Candida albicans |
| Q39684545 | Fungicidal mechanisms of cathelicidins LL-37 and CATH-2 revealed by live-cell imaging |
| Q52611998 | Fungicidal potency and mechanisms of θ-defensins against multi-drug resistant Candida species. |
| Q74619526 | Histatin 5 and derivatives. Their localization and effects on the ultra-structural level |
| Q36095359 | Histatin 5 initiates osmotic stress response in Candida albicans via activation of the Hog1 mitogen-activated protein kinase pathway |
| Q34684434 | Histatin 5 resistance of Candida glabrata can be reversed by insertion of Candida albicans polyamine transporter-encoding genes DUR3 and DUR31. |
| Q35626181 | Histatin 5 uptake by Candida albicans utilizes polyamine transporters Dur3 and Dur31 proteins. |
| Q24313429 | Histidine-rich glycoprotein protects from systemic Candida infection |
| Q37276479 | Host defense peptides in the oral cavity and the lung: similarities and differences |
| Q38222086 | How does it kill?: understanding the candidacidal mechanism of salivary histatin 5. |
| Q39091774 | Human Antimicrobial Peptides in Bodily Fluids: Current Knowledge and Therapeutic Perspectives in the Postantibiotic Era. |
| Q35635804 | Human beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption |
| Q24537545 | Human salivary histatin 5 causes disordered volume regulation and cell cycle arrest in Candida albicans |
| Q35006531 | Human salivary histatin 5 fungicidal action does not induce programmed cell death pathways in Candida albicans |
| Q34729481 | Identification and mechanism of action of the plant defensin NaD1 as a new member of the antifungal drug arsenal against Candida albicans |
| Q41125894 | Impaired Histatin-5 Levels and Salivary Antimicrobial Activity against C. albicans in HIV Infected Individuals |
| Q33979652 | In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1. |
| Q34553406 | Influence of histatin 5 on Candida albicans mitochondrial protein expression assessed by quantitative mass spectrometry |
| Q97540684 | Inhibition of the ATP synthase sensitizes Staphylococcus aureus towards human antimicrobial peptides |
| Q48163042 | Innate Immunity to Mucosal Candida Infections. |
| Q42013682 | Interactions of histatin 5 and histatin 5-derived peptides with liposome membranes: surface effects, translocation and permeabilization |
| Q35012918 | Killing of Candida albicans by human salivary histatin 5 is modulated, but not determined, by the potassium channel TOK1. |
| Q29871517 | MUC7 20-Mer: investigation of antimicrobial activity, secondary structure, and possible mechanism of antifungal action |
| Q24630137 | Modulation of in vitro fungicidal activity of human lactoferrin against Candida albicans by extracellular cation concentration and target cell metabolic activity |
| Q35163819 | Molecular targeted treatments for fungal infections: the role of drug combinations |
| Q28477224 | Phage displayed short peptides against cells of Candida albicans demonstrate presence of species, morphology and region specific carbohydrate epitopes |
| Q39538292 | Possible release of an ArgGlyArgProGln pentapeptide with innate immunity properties from acidic proline-rich proteins by proteolytic activity in commensal streptococcus and actinomyces species |
| Q33849225 | Potent in vitro and in vivo antifungal activity of a small molecule host defense peptide mimic through a membrane-active mechanism |
| Q40075939 | Preventive effects of the novel antimicrobial peptide Nal-P-113 in a rat Periodontitis model by limiting the growth of Porphyromonas gingivalis and modulating IL-1β and TNF-α production |
| Q38079168 | Properties and mechanisms of action of naturally occurring antifungal peptides |
| Q33951843 | Purinergic signaling at immunological synapses |
| Q42082714 | Reactive oxygen species play no role in the candidacidal activity of the salivary antimicrobial peptide histatin 5. |
| Q34005242 | Released ATP is an extracellular cytotoxic mediator in salivary histatin 5-induced killing of Candida albicans |
| Q33980976 | Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways. |
| Q34017572 | Salivary histatin 5 internalization by translocation, but not endocytosis, is required for fungicidal activity in Candida albicans |
| Q37219481 | Sensitivity of Candida albicans biofilm cells grown on denture acrylic to antifungal proteins and chlorhexidine |
| Q36730043 | Sustained Nitric Oxide-Releasing Nanoparticles Induce Cell Death in Candida albicans Yeast and Hyphal Cells, Preventing Biofilm Formation In Vitro and in a Rodent Central Venous Catheter Model |
| Q44754602 | Synergistic Activity between Two Antifungal Proteins, the Plant Defensin NaD1 and the Bovine Pancreatic Trypsin Inhibitor. |
| Q34973666 | Synthetic histidine-rich peptides inhibit Candida species and other fungi in vitro: role of endocytosis and treatment implications |
| Q37548771 | Synthetic multivalent antifungal peptides effective against fungi |
| Q92988294 | Systematical Analysis of the Protein Targets of Lactoferricin B and Histatin-5 Using Yeast Proteome Microarrays |
| Q36424968 | The P-113 fragment of histatin 5 requires a specific peptide sequence for intracellular translocation in Candida albicans, which is independent of cell wall binding |
| Q27318386 | The antimicrobial peptide histatin-5 causes a spatially restricted disruption on the Candida albicans surface, allowing rapid entry of the peptide into the cytoplasm |
| Q33952105 | The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species |
| Q40730220 | The role of released ATP in killing Candida albicans and other extracellular microbial pathogens by cationic peptides |
| Q28202577 | Zinc and copper bind to unique sites of histatin 5 |
Search more.